Jim Lykins is a Vice President and Research Analyst at D.A. Davidson & Co. and joined the company in November 2015 to expand coverage of the real estate sector, focusing on retail. Previously, he was the Acquisitions Manager at Whitestone REIT, a publicly traded retail REIT based in Houston. Prior to that, he spent 14 years at Hilliard Lyons, including 12 years in equity research covering utilities and two years in investment banking focusing on REITs. Mr. Lykins was named Thomson Reuters’ “Top Stock Picker” in Equity Real Estate Investment Trusts in 2017. He holds an MBA from Bellarmine College and a BBA in finance from the University of Kentucky.
Jade Rahmani is a Managing Director at Keefe, Bruyette & Woods, Inc. He joined KBW in 2007 and covers the commercial real estate finance sector. Previously, he was an Equity Analyst at Prudential Securities, covering industrial companies including aerospace and defense. Mr. Rahmani was named the #1 Stock Picker in Housing Durables in 2012 and 2015, and #3 in Earnings Estimate Accuracy in 2016 by StarMine. Earlier in his career, he worked at UBS on strategic marketing initiatives and at Sidley Austin on real estate finance transactions. Mr. Rahmani received a B.A. in English from the University of Michigan, Ann Arbor and an MBA in Finance and Accounting from New York University’s Leonard N. Stern School of Business.
John Campbell is a Managing Director and Research Analyst at Stephens Inc. covering real estate-related stocks across a handful of industries. He joined Stephens in 2011 as a research associate in the business services and insurance brokerage space. Mr. Campbell was promoted into a lead analyst role in 2014, and has since built and currently leads the firm’s Real Estate Services practice. Prior to joining Stephens, Mr. Campbell spent time as a corporate strategy planning analyst at FedEx. He holds a B.A. in banking & finance and an MBA from Ole Miss.
Jeremy Metz joined BMO Capital Markets in 2017 and is Managing Director and Senior Analyst covering the U.S. REIT sector along with John Kim. Previously, Mr. Metz worked at UBS Securities, where he was a senior analyst on their number-four Institutional Investor-ranked U.S. REIT team. Prior to that, he was Vice President of Deutsche Bank’s Global Markets Research. Mr. Metz also held positions at Louis Dreyfus Investment Group, where he was Co-Head of Real Estate Acquisitions, and J.P. Morgan Asset Management, where he was Vice President, real estate acquisitions and asset management. Mr. Metz holds a B.A. in business economics from Brown University.
Robert Michael Maltbie Jr., CFA, is the Managing Director and President at Singular Research, LLC. He is also General Partner, Managing Director, Chief Compliance Officer, and Portfolio Manager at Millennium Asset Management. He received a degree in political science from UCLA.
Jason Deleeuw, CFA, is a Vice President and Senior Research Analyst at Piper Jaffray & Co., covering financial and business services companies. He had worked as a research analyst at Piper Jaffray from 2006 to 2011 covering financial services companies. Prior to rejoining Piper Jaffray in 2014, Mr. Deleeuw was a senior analyst on the financial equities long/short team at Pine River Capital from 2011 to 2014. Mr. Deleeuw has a bachelor’s degree in economics from Macalester College and a Master of Business Administration degree from the University of Minnesota.
John DeCree is Director, Head of North America Equity/High Yield Research, New York, at Union Gaming. Mr. DeCree has spent 10 years in capital markets focusing on the casino and gaming industry. Mr. DeCree joined Union Gaming in 2014 to focus primarily on North America equity research. Prior to joining Union Gaming, Mr. DeCree served as an Equity Research Analyst at Telsey Advisory Group, covering the global gaming, lodging and leisure sectors. Previous to his tenure at Telsey Advisory Group, Mr. DeCree spent five years in leveraged finance at The GMS Group focusing on the global gaming industry.
Debjit Chattopadhyay is a Managing Director and Senior Healthcare Analyst of H.C. Wainwright & Co. Debjit Chattopadhyay is focused on health care research at HCW, specializing in biotechnology with a core focus on gene therapy, immune-oncology and rare diseases. Dr. Chattopadhyay has been a Wall Street health care analyst, on sellside, since 2006. Dr. Chattopadhyay’s previous sellside experience includes Janney Montgomery Scott, Roth Capital Partners and Boenning & Scattergood. Most recently, Dr. Chattopadhyay was the Managing Director and head of biotechnology at Janney Montgomery Scott. Dr. Chattopadhyay received his Ph.D. from the University of Connecticut and has served as an oncology research fellow at Memorial Sloan Kettering Cancer Center and also holds a Master of Business Administration — MBA — degree from Drexel University.
John Vandermosten, CFA, is a senior biotechnology research analyst for Zacks SCR where he covers a portfolio of small-cap equities. His background includes 20 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. Formerly, Mr. Vandermosten was a research analyst for Singular Research covering the health care space and a consultant with Coker Group, a national health care services firm providing financial services to health care organizations. At Coker Group he consulted with clients in a variety of strategic and financial areas, including asset valuations, due diligence and transactions. Prior to his role as sell-side analyst and consultant, Mr. Vandermosten was a portfolio manager at Westwood Holdings Group and covered health care and other spaces as a research analyst. Mr. Vandermosten was also an analyst at the Teacher Retirement System of Texas. Mr. Vandermosten has an MBA from Texas A&M University, an M.A. from Tulane University and a B.A. from San Diego State University. He has also earned the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Dallas.
Robert Balsamo Jr. is Senior Vice President and Senior Research Analyst of B. Riley FBR, Inc. Mr. Balsamo came to FBR — now B. Riley FBR, Inc. — from UBS Securities, LLC, where he served as a director and analyst focused on MLP research. Prior to UBS, he held energy-focused research and investment banking positions at Global Hunter Securities, LLC. He holds a B.A. from Colgate University and an MBA from Tulane University.
